A new study carried out between 2003 and 2012 in the Journal of the American Medical Association of nearly 162,000 patients in 164 studies (37 randomized clinical trials and 127 observational studies), over almost 10 years was released compared to a similar study reported in 2004.
Researchers discovered 92 percent of patients in randomized clinical trials experienced diabetes remission after surgery, slightly higher than the 86 percent remission rate found in observational studies, but significantly higher than the 76.8 percent remission rate found in the 2004 JAMA study. Remission rates for hypertension were about 75 percent in both the randomized clinical trials and observational studies, while the remission rate in 2004 was 61.7 percent.
In the new study, 30-day mortality rate was 0.08 percent, down from the 0.3 percent reported in 2004. Complication rates ranged from 10 to 17 percent and the reoperation rate was about 7 percent. The data continues to prove bariatric surgery is not only safe and effective in providing significant and sustainable weight loss, but is the most effective treatment today for diabetes, hypertension and an array of other diseases and conditions in people with obesity.
“This is but the latest study to validate the high degree of safety and effectiveness of bariatric surgery,” said Ninh T. Nguyen, MD, FACS, and President of the American Society for Metabolic and Bariatric Surgery (ASMBS) and Vice-Chair of the Department of Surgery at UC Irvine School of Medicine. “Today we are performing operations that are as safe as or safer than gallbladder and hernia repair surgery.”